AGP Executive Report
Last update: 9 hours agoCancer Care in China: NMPA approved T-DXd (Enhertu) plus pertuzumab for first-line treatment of unresectable or metastatic HER2+ breast cancer, with DESTINY-Breast09 showing a major PFS improvement versus standard therapy. AI Use at Work: A new report finds some CIOs and CTOs are tightening AI access with usage caps as costs rise, shifting staff toward smaller, cheaper models. Public Health Nutrition Research: A large study using UK Biobank data links plant-forward eating patterns (including the EAT-Lancet style) with lower chronic kidney disease risk over about 12 years. Metabolic & Heart Health: Clinical research continues to test amla (Indian gooseberry) for cholesterol and blood-sugar control, reporting benefits with generally mild side effects. Water & Health Infrastructure: China’s Yellow River has maintained uninterrupted flow for 27 straight years, supported by tighter regulation and ecological water replenishment. Local Fiscal Pressure on Care Workers: Reports say some local governments are clawing back past bonuses and allowances, including pandemic-related pay, adding stress for medical staff and other public workers. Digital Health in Egypt (China-linked): Egypt’s health ministry discussed expanding Huawei-led healthcare digital transformation, including integrated data platforms and AI-enabled hospital systems.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
